Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
40
MLYS Quote, Financials, Valuation and Earnings
Last price:
$37.30
Seasonality move
:
41.51%
Day range:
$36.51 - $38.23
52-week range:
$8.24 - $47.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.16x
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
209.7%
Market cap:
$3B
Revenue:
--
EPS (TTM):
-$2.96
Earnings Data
Next earnings date for MLYS
Feb 12
2026
Most recent earnings per share
-$0.52
Beat by $0.09
(Nov 10/2025)
Consensus Estimate
-$0.61
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MLYS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | -- | -- | -- | -$0.53 | -- |
| 11/10/2025 | Q3 | -- | -- | -$0.52 | -$0.61 | $0.09 |
| 08/12/2025 | Q2 | -- | -- | -$0.66 | -$0.74 | $0.08 |
| 05/08/2025 | Q1 | -- | -- | -$0.79 | -$0.98 | $0.19 |
| 02/12/2025 | Q4 | -- | -- | -$0.98 | -$1.08 | $0.10 |
| 11/11/2024 | Q3 | -- | -- | -$1.13 | -$0.83 | -$0.30 |
| 08/13/2024 | Q2 | -- | -- | -$0.83 | -$0.70 | -$0.13 |
| 05/09/2024 | Q1 | -- | -- | -$0.70 | -$0.67 | -$0.03 |
| 03/21/2024 | Q4 | -- | -- | -$0.61 | -$0.83 | $0.22 |
| 11/07/2023 | Q3 | -- | -- | -$0.55 | -- | -- |
| 08/07/2023 | Q2 | -- | -- | -$0.30 | -- | -- |
| 05/15/2023 | Q1 | -- | -- | -$0.31 | -- | -- |
| 03/15/2023 | Q4 | -- | -- | -$0.22 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$1.29 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.16 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.46 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.12 | -- | -- |
Mineralys Therapeutics, Inc. Earnings Questions
-
How Much did Mineralys Therapeutics, Inc. Generate in Revenue Last Quarter?
Mineralys Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Mineralys Therapeutics, Inc. Beat Earnings Last Quarter?
Mineralys Therapeutics, Inc. announced earnings per share of -$0.52 which represents a beat of analyst forecast a -$0.61 per share.
-
Is Mineralys Therapeutics, Inc. Profitable?
Mineralys Therapeutics, Inc. reported -$15K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Mineralys Therapeutics, Inc. EPS Next Year?
Mineralys Therapeutics, Inc.'s earnings are forecast to decrease from -$3.66 per share to -$3.71 per share next year representing a decrease of -34.56%.
-
When is Mineralys Therapeutics, Inc.'s Earnings Date?
Mineralys Therapeutics, Inc.'s next earnings date is February 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
